Pei, 2022 - Google Patents
Designing Cell-Permeable Peptide Therapeutics That Enter the Cell by EndocytosisPei, 2022
View HTML- Document ID
- 12644240042122288872
- Author
- Pei D
- Publication year
- Publication venue
- Approaching the Next Inflection in Peptide Therapeutics: Attaining Cell Permeability and Oral Bioavailability
External Links
Snippet
Intracellular protein-protein interactions (PPIs) represent a large class of exciting yet challenging drug targets for traditional drug modalities (ie, small molecules and biologics). Peptides (especially cyclic peptides) have proven highly effective as PPI inhibitors in vitro …
- 239000003814 drug 0 title abstract description 25
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ji et al. | Cyclic peptides for drug development | |
Dougherty et al. | Understanding cell penetration of cyclic peptides | |
Rhodes et al. | Bicyclic peptides as next‐generation therapeutics | |
Peraro et al. | Emerging methods and design principles for cell‐penetrant peptides | |
White et al. | Contemporary strategies for peptide macrocyclization | |
Dougherty et al. | Macrocycles as protein–protein interaction inhibitors | |
CN106852146B (en) | Cell penetrating peptides and methods of making and using the same | |
Bird et al. | Synthesis and Biophysical Characterization of Stabilized α‐Helices of BCL‐2 Domains | |
Liu et al. | Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1 | |
Sellers et al. | Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives | |
Freeman et al. | Microwave-assisted solid-phase aza-peptide synthesis: aza scan of a PKB/Akt inhibitor using aza-arginine and aza-proline precursors | |
Ahangarzadeh et al. | Bicyclic peptides: types, synthesis and applications | |
US11673919B2 (en) | Bicyclic peptidyl inhibitors | |
Claro et al. | Design and applications of cyclic peptides | |
Appiah Kubi et al. | Designing cell-permeable macrocyclic peptides | |
Testa et al. | Copper-catalyzed azide-alkyne cycloaddition (CuAAC)-mediated macrocyclization of peptides: impact on conformation and biological activity | |
He et al. | Biocompatible strategies for peptide macrocyclisation | |
Jimmidi | Synthesis and applications of peptides and peptidomimetics in drug discovery | |
Farkas et al. | Amino Acids, Peptides and Proteins: Volume 37 | |
Pei | Designing Cell-Permeable Peptide Therapeutics That Enter the Cell by Endocytosis | |
Wang et al. | Evaluation of the cell permeability of bicyclic peptoids and bicyclic peptide-peptoid hybrids | |
Herlan et al. | Cyclic peptoid-peptide hybrids as versatile molecular transporters | |
Abrigo et al. | Development of a cyclic, cell penetrating peptide compatible with in vitro selection strategies | |
Shu et al. | Synthesis of the Src SH2 domain and its application in bioassays for mirror-image screening | |
Samarasimhareddy et al. | A rapid and efficient building block approach for click cyclization of peptoids |